2020
DOI: 10.21203/rs.3.rs-25350/v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Deep Sequencing Reveals New Roles for MuB in Transposition Immunity and Target-capture, and Redefines the Insular Ter Region of E. coli

Abstract: Background The target capture protein MuB is responsible for the high efficiency of phage Mu transposition within the E. coli genome. However, some targets are off-limits, such as regions immediately outside the Mu ends (cis-immunity) as well as the entire ~37 kb genome of Mu (Mu genome immunity). Paradoxically, MuB is responsible for cis-immunity and is also implicated in Mu genome immunity, but via different mechanisms. This study was undertaken to dissect the role of MuB in target choice in vivo.Results We … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 36 publications
(62 reference statements)
0
1
0
Order By: Relevance
“…Interestingly, Mu is the most efficient transposable element known (Mizuuchi, 1983;Walker and Harshey, 2020) and can infect and lyse several hosts (Escherichia coli, Shigella sonnei, Citrobacter freundii, Erwinia, and Enterobacter) (Paolozzi and Ghelardini, 2006). Moreover, Mu-like phages were discovered in a wide range of Gramnegative and Gram-positive bacteria (Hull et al, 1978;Hayashi et al, 2001;Toussaint, 2013).…”
Section: Phage Therapy By Lytic Phage or Endolysin Proteinmentioning
confidence: 99%
“…Interestingly, Mu is the most efficient transposable element known (Mizuuchi, 1983;Walker and Harshey, 2020) and can infect and lyse several hosts (Escherichia coli, Shigella sonnei, Citrobacter freundii, Erwinia, and Enterobacter) (Paolozzi and Ghelardini, 2006). Moreover, Mu-like phages were discovered in a wide range of Gramnegative and Gram-positive bacteria (Hull et al, 1978;Hayashi et al, 2001;Toussaint, 2013).…”
Section: Phage Therapy By Lytic Phage or Endolysin Proteinmentioning
confidence: 99%